Sotalol
Side effects
Options:
Hide MedDRA Preferred Terms
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
Asthenia
|
Fatigue
|
2% - 20%
|
8.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Asthenia
|
1% - 13%
|
3.2%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Fatigue
|
Fatigue
|
2% - 20%
|
8.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Dizziness
|
Dizziness
|
1% - 20%
|
12.4%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Lightheadedness
|
1% - 12%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Syncope
|
postmarketing, 1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Dyspnoea
|
Dyspnoea
|
postmarketing, 2% - 21%
|
7.4%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Palpitations
|
Palpitations
|
postmarketing, 1% - 14%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Bradycardia
|
Bradycardia
|
postmarketing, 2% - 16%
|
2.5%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Nausea
|
Nausea
|
1% - 10%
|
5.3%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Vomiting
|
Vomiting
|
1% - 10%
|
5.3%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Hyperhidrosis
|
Hyperhidrosis
|
4.9% - 5.2%
|
3.2%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Angina pectoris
|
Cardiac pain
|
2.5% - 4.6%
|
4.6%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Angina pectoris
|
1.6% - 2%
|
1.1%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Chest pain
|
Chest pain
|
postmarketing, 1% - 16%
|
1.4%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Headache
|
Headache
|
1% - 11.5%
|
5.3%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cough
|
Cough
|
2.5% - 3.3%
|
2.5%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Pain
|
Pain
|
2.5% - 4.1%
|
2.5% - 2.8%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Pain localised
|
1% - 3%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Ache
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Diarrhoea
|
Diarrhoea
|
1% - 7%
|
2.1%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Dyspepsia
|
Dyspepsia
|
1% - 6%
|
1.8%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Heartburn
|
2% - 2.5%
|
1.8%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Oedema
|
Oedema
|
postmarketing, 1% - 8%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Dermatitis
|
Rash
|
1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Rash
|
Rash
|
1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hypotension
|
Hypotension
|
postmarketing, 2% - 6%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pain in extremity
|
Pain in extremity
|
1% - 7%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Arrhythmia
|
Proarrhythmia
|
postmarketing, 1% - 7%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Upper respiratory tract infection
|
Upper respiratory tract infection
|
2.6% - 3.3%
|
1.1%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Insomnia
|
Insomnia
|
2.6% - 4.1%
|
1.1%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Abdominal pain
|
Abdominal pain
|
1% - 3%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Gastrointestinal pain
|
Abdominal pain
|
1% - 3%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Anxiety
|
Anxiety
|
1% - 4%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Appetite disorder
|
Appetite disorder
|
1% - 3%
|
|
|
|
|
|
|
|
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Back pain
|
Back pain
|
1% - 3%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cardiovascular disorder
|
Cardiovascular disorder
|
1% - 3%
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
|
Infection
|
Infection
|
1% - 4%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Depression
|
Depression
|
1% - 4%
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
x
|
x
|
Body temperature increased
|
Body temperature increased
|
postmarketing, 1% - 4%
|
0.7%
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cardiac failure
|
Cardiac failure
|
postmarketing, 1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Influenza
|
Influenza
|
0.8% - 2%
|
0.4%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Paraesthesia
|
Paraesthesia
|
1% - 4%
|
|
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Shock
|
Syncope
|
postmarketing, 1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Syncope
|
Syncope
|
postmarketing, 1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Loss of consciousness
|
Syncope
|
postmarketing, 1% - 5%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Decreased appetite
|
Decreased appetite
|
1.6% - 2%
|
0.4%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Altered state of consciousness
|
Consciousness abnormal
|
1% - 4%
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Electrocardiogram abnormal
|
Electrocardiogram abnormal
|
1% - 7%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Presyncope
|
Presyncope
|
postmarketing, 1% - 4%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Torsade de pointes
|
Torsade de pointes
|
1% - 4.1%
|
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Asthma
|
Asthma
|
1% - 2%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Flatulence
|
Flatulence
|
1% - 2%
|
|
x
|
x
|
x
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Haemorrhage
|
Haemorrhage
|
1% - 2%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Haemoglobin
|
Haemorrhage
|
1% - 2%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hypertension
|
Hypertension
|
1% - 2%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Vasodilation procedure
|
Vasodilation
|
1% - 3%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Urogenital disorder
|
Urogenital disorder
|
0% - 3%
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Peripheral vascular disorder
|
Peripheral vascular disorder
|
1% - 3%
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
|
Mood swings
|
Mood swings
|
1% - 3%
|
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Affect lability
|
Mood swings
|
1% - 3%
|
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Sexual dysfunction
|
Sexual dysfunction
|
1% - 3%
|
|
x
|
x
|
x
|
|
|
|
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
|
Abdominal distension
|
Distention
|
0.7% - 2.5%
|
0.4%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Tracheobronchitis
|
Tracheobronchitis
|
0.7% - 3.3%
|
0.7%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
x
|
Ventricular tachycardia
|
Sustained ventricular tachycardia
|
0.3% - 1.2%
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ventricular tachycardia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Multifocal ventricular tachycardia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Non-sustained ventricular tachycardia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cerebrovascular accident
|
Cerebrovascular accident
|
1%
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Alopecia
|
Alopecia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Alopecia reversible
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Eosinophilia
|
Eosinophilia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hyperlipidaemia
|
Hyperlipidaemia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Leukopenia
|
Leukopenia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pruritus
|
Pruritus
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pulmonary oedema
|
Pulmonary oedema
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Thrombocytopenia
|
Thrombocytopenia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Vertigo
|
Vertigo
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Photosensitivity reaction
|
Photosensitivity reaction
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Myalgia
|
Myalgia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Musculoskeletal discomfort
|
Myalgia
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Coordination abnormal
|
Coordination abnormal
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Paralysis
|
Paralysis
|
postmarketing
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Agranulocytosis
|
Agranulocytosis
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Atrioventricular block
|
Atrioventricular block
|
|
|
x
|
|
|
|
x
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Bronchospasm
|
Bronchospasm
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Catatonia
|
Catatonia
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Sudden death
|
Sudden death
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Somnolence
|
Drowsiness
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dysgeusia
|
Dysgeusia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hyperglycaemia
|
Hyperglycaemia
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Hyperinsulinism
|
Hyperinsulinism
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Blood insulin increased
|
Hyperinsulinism
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Laryngospasm
|
Laryngospasm
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Lethargy
|
Lethargy
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Muscle spasms
|
Cramp muscle
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Myocardial infarction
|
Myocardial infarction
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acute coronary syndrome
|
Myocardial infarction
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peyronie's disease
|
Peyronie's disease
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Neuropathy peripheral
|
Neuropathy peripheral
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Purpura
|
Purpura
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Vascular purpura
|
Purpura
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Retroperitoneal fibrosis
|
Retroperitoneal fibrosis
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiogenic shock
|
Cardiogenic shock
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sleep disorder
|
Sleep disturbance
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Angiopathy
|
Angiopathy
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Ventricular fibrillation
|
Ventricular fibrillation
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tachyarrhythmia
|
Tachyarrhythmia
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Atrioventricular block first degree
|
Atrioventricular block first degree
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Photophobia
|
Photophobia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ventricular extrasystoles
|
Ventricular extrasystoles
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Electrocardiogram QT prolonged
|
Electrocardiogram QT prolonged
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arterial thrombosis
|
Arterial thrombosis
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Colitis ischaemic
|
Colitis ischaemic
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Disorientation
|
Disorientation
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Eye irritation
|
Eye irritation
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oropharyngeal discomfort
|
Throat sore
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Oropharyngeal pain
|
Throat sore
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Peripheral coldness
|
Peripheral coldness
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Atrophy
|
Atrophy
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vision blurred
|
Vision blurred
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Respiratory distress
|
Respiratory distress
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Visual impairment
|
Visual disturbance
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amnesia
|
Short-term memory loss
|
|
|
|
|
|
|
|
|
|
x
|
x
|
|
|
|
|
|
|
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 51 |
Source: | Medsafe |
---|
Side effects: | 53 |
Source: | medicines.org.au |
---|
Side effects: | 53 |
Source: | medicines.org.au |
---|
Side effects: | 41 |
Source: | FDA |
---|
Side effects: | 42 |
Source: | FDA Structured Product Label |
---|
Side effects: | 43 |
Source: | FDA Structured Product Label |
---|
Side effects: | 43 |
Source: | FDA Structured Product Label |
---|
Side effects: | 66 |
Source: | Health Canada |
---|
Side effects: | 67 |
Source: | Health Canada |
---|
Side effects: | 51 |
Source: | FDA Structured Product Label |
---|
Side effects: | 59 |
Source: | FDA Structured Product Label |
---|
Side effects: | 59 |
Source: | FDA Structured Product Label |
---|
Side effects: | 59 |
Source: | FDA Structured Product Label |
---|
Side effects: | 59 |
Source: | FDA Structured Product Label |
---|
Side effects: | 60 |
Source: | FDA Structured Product Label |
---|
Side effects: | 72 |
Source: | FDA Structured Product Label |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|